Ophthotech Reports Third Quarter 2018 Financial and Operating Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Ophthotech Corp (OPHT) Tops Q3 EPS by 2c
October 31, 2018 6:42 AM EDTOphthotech Corp (NASDAQ: OPHT) reported Q3 EPS of ($0.41), $0.02 better than the analyst estimate of ($0.43).
During 2018 Ophthotech made significant progress in bringing together a diversified pipeline of therapeutic and gene therapy programs for the treatment of retinal diseases, stated Glenn P. Sblendorio, Chief Executive Officer... More



